相关实验视频

Updated: Jul 9, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

针对抗MDA5抗体阳性皮肤肌炎-快速进展的间歇性肺病的激进多组合疗法

Kenichiro Hata¹, Takuya Kotani¹, Shogo Matsuda¹

¹Department of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.

International journal of rheumatic diseases

|December 8, 2023

概括

积极的组合疗法改善了抗黑色素瘤分化关联基因5 (MDA5) 抗体阳性皮肤肌炎 (DM) 患者的存活率,并具有快速进展的间歇性肺病 (RPILD). 精心管理诸如白血病症等并发症对于这种治疗至关重要.

科学领域:

类风湿病学类风湿病学
肺部病理学肺部病理学
免疫学免疫学免疫学

背景情况:

抗黑色素瘤分化相关基因5 (MDA5) 抗体阳性皮肤肌炎 (DM) 可能导致快速进展的间歇性肺病 (RPILD).
对于严重的DM-RPILD病例,标准治疗可能并不总是足够的.

研究的目的:

评估针对抗MDA5抗体阳性DM-RPILD的积极多组合疗法的疗效和安全性.
为了比较这种积极的方法与传统疗法.

主要方法:

总共有23名患有抗MDA5抗体阳性DM-RPILD的患者被分析.
组A (n=9) 接受了常规治疗;组B (n=14) 接受了积极的多组合治疗,包括mycophenolate mofetil,rituximab和血交换或输血.

主要成果:

积极治疗组 (B组) 在48周的累积存活率明显高于常规治疗组 (A组) (64.3%对33.3%).
B组需要在3个月和12个月后显著降低皮质类固醇剂量.
白血病在B组更频繁,尽管感染发病率没有差异.

结论:

积极的多组合疗法可以提高抗MDA5抗体阳性DM-RPILD患者的生存结果.
密切监测和管理潜在的并发症,如白血病和机会性感染是必不可少的.
需要进一步的长期研究来评估这种治疗策略的持续疗效,安全性和成本效益.

关键词:

抗MDA5抗体的使用.皮肤肌肉炎 (dermatomyositis) 是一种疾病.免疫抑制疗法是一种免疫抑制疗法.间歇性肺病间歇性肺病

更多相关视频

Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers

Author Spotlight: Optimized Protocol for Detecting Antigen-Specific T Cells in Mouse Lungs Using Tetramers

Published on: July 19, 2024

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...